Table 1. Patient demographic characteristics according to period between initial symptoms and clinical progression to COVID-19 suspicion (PISYCS).
| Period between initial symptoms and clinical progression to COVID-19 suspicion (PISYCS) | Global P Value | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| <24 Hrs (n = 9759) | 1–3 Days (n = 28331) | 4–7 Days (n = 20877) | >7 Days (n = 6533) | |||||||
| N | % | N | % | N | % | N | % | |||
| Gender | Female | 4686 | 14.3%* | 14371 | 43.7% | 10562 | 32.1% | 3260 | 9.9% | <0.001 |
| Male | 5073 | 15.6% | 13960 | 42.8% | 10315 | 31.6% | 3273 | 10.0% | ||
| Age | < 30 | 2469 | 15.0%* | 7965 | 48.4% | 4732 | 28.7%** | 1302 | 7.9%*** | <0.001 |
| 30–49 | 3745 | 12.8% | 12813 | 43.6% | 9785 | 33.3% | 3016 | 10.3% | ||
| 50–59 | 1430 | 14.7% | 3875 | 39.7% | 3321 | 34.1% | 1123 | 11.5% | ||
| 60–69 | 1095 | 19.8% | 2006 | 36.2% | 1785 | 32.2% | 656 | 11.8% | ||
| 70–79 | 615 | 21.9% | 1018 | 36.3% | 863 | 30.7% | 311 | 11.1% | ||
| > 80 | 405 | 25.7% | 654 | 41.5% | 391 | 24.8% | 125 | 7.9% | ||
| Mean (SD) | 43(20)* | 40 (18) | 42 (17)** | 44 (16)*** | <0.001 | |||||
| State’s Socioeconomic Status | High | 5532 | 15.1%* | 15745 | 43.1% | 11352 | 31.1%** | 3921 | 10.7%*** | <0.001 |
| Medium | 2878 | 15.8% | 8027 | 44.2% | 5868 | 32.3% | 1402 | 7.7% | ||
| Low | 1349 | 12.5% | 4559 | 42.3% | 3657 | 33.9% | 1210 | 11.2% | ||
| Health Sector | Private | 468 | 15.6%* | 1228 | 40.9% | 885 | 29.5%** | 418 | 13.9%*** | <0.001 |
| With SS | 4584 | 18.6% | 10515 | 42.6% | 7274 | 29.5% | 2321 | 9.4% | ||
| Without SS | 4707 | 12.5% | 16588 | 43.9% | 12718 | 33.6% | 3794 | 10.0% | ||
| Indigenous Language Speaker | Yes | 98 | 14.4% | 277 | 40.8% | 242 | 35.6% | 62 | 9.1% | 0.20 |
| No | 9661 | 14.9% | 28054 | 43.4% | 20635 | 31.8% | 6471 | 10.0% | ||
| Pregnancy | Yes | 139 | 18.3% | 383 | 50.5% | 190 | 25.1%** | 46 | 6.1%*** | <0.001 |
| No | 9620 | 14.9% | 27948 | 43.2% | 20687 | 32.0% | 6487 | 10.0% | ||
| Tobacco Use | Yes | 946 | 14.5% | 2786 | 42.8% | 2122 | 32.6% | 661 | 10.1% | 0.49 |
| No | 8813 | 14.9% | 25545 | 43.3% | 18755 | 31.8% | 5872 | 10.0% | ||
| Diabetes | Yes | 1514 | 18.1%* | 3307 | 39.5% | 2684 | 32.1%** | 867 | 10.4%*** | <0.001 |
| No | 8245 | 14.4% | 25024 | 43.8% | 18193 | 31.8% | 5666 | 9.9% | ||
| COPD | Yes | 401 | 22.6%* | 685 | 38.6% | 535 | 30.2% | 153 | 8.6% | <0.001 |
| No | 9358 | 14.7% | 27646 | 43.4% | 20342 | 31.9% | 6380 | 10.0% | ||
| Asthma | Yes | 394 | 12.4%* | 1422 | 44.6% | 1034 | 32.5% | 336 | 10.5% | 0.001 |
| No | 9365 | 15.0% | 26909 | 43.2% | 19843 | 31.8% | 6197 | 9.9% | ||
| Immunosuppression | Yes | 455 | 26.1%* | 697 | 40.0% | 429 | 24.6%** | 163 | 9.3% | <0.001 |
| No | 9304 | 14.6% | 27634 | 43.3% | 20448 | 32.1% | 6370 | 10.0% | ||
| Hypertension | Yes | 1932 | 17.4%* | 4415 | 39.7% | 3593 | 32.3%** | 1194 | 10.7%*** | <0.001 |
| No | 7827 | 14.4% | 23916 | 44.0% | 17284 | 31.8% | 5339 | 9.8% | ||
| Cardiovascular Disease | Yes | 470 | 22.0%* | 820 | 38.3% | 627 | 29.3% | 224 | 10.5%*** | <0.001 |
| No | 9289 | 14.7% | 27511 | 43.4% | 20250 | 32.0% | 6309 | 10.0% | ||
| Obesity | Yes | 1381 | 13.5% | 4093 | 40.0% | 3633 | 35.5%** | 1119 | 10.9%*** | <0.001 |
| No | 8378 | 15.2% | 24238 | 43.9% | 17244 | 31.2% | 5414 | 9.8% | ||
| Chronic Kidney Disease | Yes | 435 | 28.1%* | 612 | 39.5% | 374 | 24.1%** | 129 | 8.3% | <0.001 |
| No | 9324 | 14.6% | 27719 | 43.3% | 20503 | 32.1% | 6404 | 10.0% | ||
| Other Comorbid Condition | Yes | 662 | 19.0%* | 1440 | 41.3% | 1059 | 30.4% | 323 | 9.3% | <0.001 |
| No | 9097 | 14.7% | 26891 | 43.4% | 19818 | 32.0% | 6210 | 10.0% | ||
SS = Social Security. COPD = Chronic Obstructive Pulmonary Disease. SD = Standard Deviation. Statistical Significance p<0.05
* Significant Difference between periods of <24 hrs. and 1–3 days
** Significant Difference between periods of 4–7 days and 1–3 days.
*** Significant Difference between periods of >7 days and 1–3 days.